Antioxidant status in experimental type 2 diabetes mellitus: effects of glibenclamide and glipizide on various rat tissues. (Q48137911)

9 February 2018

title

Antioxidant status in experimental type 2 diabetes mellitus: effects of glibenclamide and glipizide on various rat tissues. (English)

1 reference

9 February 2018

1 reference

Tüzün S

1

1 reference

9 February 2018

Girgin FK

2

1 reference

9 February 2018

Sözmen EY

3

1 reference

9 February 2018

Menteş G

4

1 reference

9 February 2018

Ersöz B

5

1 reference

9 February 2018

publication date

1 July 1999

1 reference

9 February 2018

Experimental and Toxicologic Pathology

published in

1 reference

9 February 2018

volume

51

1 reference

9 February 2018

issue

4-5

1 reference

9 February 2018

page(s)

436-441

1 reference

9 February 2018

Impaired antioxidant status in diabetic rat liver. Effect of vanadate

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

7 January 2021

Lipid peroxidation products and antioxidant enzymes in red blood cells during normal and diabetic pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

7 January 2021

Poor glycaemic control is associated with reduced serum free radical scavenging (antioxidant) activity in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

7 January 2021

Effect of the sulfonylurea glyburide on superoxide dismutase activity in alloxan-induced diabetic rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

1 reference

7 January 2021

Lipid peroxidation in early experimental diabetes in rats: effects of diabetes and insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

7 January 2021

Plasma acetate levels in response to intravenous fat or glucose/insulin infusions in diabetic and non-diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

7 January 2021

The biochemistry of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

7 January 2021

The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

7 January 2021

Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

7 January 2021

Brain energy metabolism in streptozotocin-diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

7 January 2021

Effects of copper deficiency and experimental diabetes on tissue antioxidant enzyme levels in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

7 January 2021

Comparison of efficacy, secondary failure rate, and complications of sulfonylureas

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

7 January 2021

Pharmacokinetic Optimisation of Oral Hypoglycaemic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

7 January 2021

Gliclazide: a general free radical scavenger

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

7 January 2021

Effect of glipizide on insulin secretion and insulin metabolism in obese type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0940-2993%2899%2980036-0

7 January 2021

10.1016/S0940-2993(99)80036-0

Identifiers

DOI

0 references

PubMed ID

10445412

1 reference

9 February 2018